Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression

Article English OPEN
Xu X; Shen H; Zhu L; Lu J; Zhang L; Luo Z; Wu Y;
(2017)
  • Publisher: Dove Medical Press
  • Journal: OncoTargets and therapy, volume 10, pages 1,827-1,834 (issn: 1178-6930, eissn: 1178-6930)
  • Publisher copyright policies & self-archiving
  • Identifiers: doi: 10.2147/OTT.S93164, pmc: PMC5370064
  • Subject: Anti-cancer therapy | Inflammatory breast cancer | proliferation | OncoTargets and Therapy | siRNA; | RC254-282 | gene silencing | apoptosis | Original Research | cell cycle arrest | RhoC | Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Xu-Dong Xu,1 Han-Bin Shen,1 Li Zhu,2 Jian-Qin Lu,2 Lin Zhang,3 Zhi-Yong Luo,3 Ya-Qun Wu3 1Department of Thyroid and Breast Surgery, The Fifth Hospital of Wuhan, Hanyang District, 2Department of Oncology, 3Department of Thyroid and Breast Surgery, Tongji Hospital, Tongj... View more
Share - Bookmark